esophageal cancer
Conditions
Interventions
Surgery group / neoadjuvant chemotherapy + surgery group:neoadjuvant chemotherapy
Sponsors
Second Hospital of Shandong University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Preoperative endoscopic biopsy pathology confirmed esophageal squamous cell carcinoma, endoscopy, and endoscopic ultrasound comprehensive assessment of tumor location and depth of invasion, chest and abdomen enhanced by CT comprehensive assessment of tumor invasion and the number of suspected lymph node metastasis, if necessary (T1-2N2, T3N1-2, T4aN0-2), and some patients with stage II (such as stage III, stage III, and stage III) were treated with endoscopic ultrasonography or B-mode ultrasonography. T1-2N1 or other patients with stage II will also be enrolled).
Exclusion criteria
Exclusion criteria: Liver, lung, brain, kidney and other organ complications; esophageal cancer associated with perforation to the lungs to form a lung abscess, thoracic tumor, a history of malignancy; TNM stage IIIc-IV (T4b or N3 or M1); The lower esophageal cancer cervical lymph node metastasis or cervical esophageal cancer, celiac artery lymph node metastasis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of circulating tumor cells; | — |
Countries
China
Contacts
Public ContactWei-di Zhang
School of Medicine and Life Science, University of Jinan, Shandong Academy of Medical Science, Shandong cancer hospital affiliated to Shandong University, Shandong Academy of Medical Science
Outcome results
None listed